These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8454348)

  • 1. Superoxide dismutase and the resistance of Escherichia coli to phagocytic killing by human neutrophils.
    Papp-Szabò E; Sutherland CL; Josephy PD
    Infect Immun; 1993 Apr; 61(4):1442-6. PubMed ID: 8454348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superoxide dismutase protects Escherichia coli against killing by human serum.
    McManus DC; Josephy PD
    Arch Biochem Biophys; 1995 Feb; 317(1):57-61. PubMed ID: 7872803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative granulocyte chemiluminescence in the rapid detection of impaired opsonization of Escherichia coli.
    Stevens P; Young LS
    Infect Immun; 1977 Jun; 16(3):796-804. PubMed ID: 70407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Killing of alpha-haemolytic and non-haemolytic Escherichia coli strains in human serum and polymorphonuclear leucocytes.
    Siegfried L; Puzová H; Kmetová M; Kerestesová A
    J Med Microbiol; 1992 Jul; 37(1):3-7. PubMed ID: 1625312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of Escherichia coli strains carrying plasmid(s) and their plasmidless derivatives to bactericidal activity of human serum and polymorphonuclear leukocytes.
    Siegfried L; Puzová H
    Acta Microbiol Hung; 1991; 38(2):107-15. PubMed ID: 1805497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of activation by complement of group II phospholipase A2 acting against Escherichia coli.
    Madsen LM; Inada M; Weiss J
    Infect Immun; 1996 Jul; 64(7):2425-30. PubMed ID: 8698462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenesis in Escherichia coli K-12 mutants defective in superoxide dismutase or catalase.
    Prieto-Alamo MJ; Abril N; Pueyo C
    Carcinogenesis; 1993 Feb; 14(2):237-44. PubMed ID: 8382113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Septicemia-inducing Escherichia coli O115:K"V165"F165(1) resists killing by porcine polymorphonuclear leukocytes in vitro: role of F165(1) fimbriae and K"V165" O-antigen capsule.
    Ngeleka M; Martineau-Doizé B; Fairbrother JM
    Infect Immun; 1994 Feb; 62(2):398-404. PubMed ID: 7507891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalase and superoxide dismutase in Escherichia coli.
    Schwartz CE; Krall J; Norton L; McKay K; Kay D; Lynch RE
    J Biol Chem; 1983 May; 258(10):6277-81. PubMed ID: 6304032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of capsular polysaccharide K21b of Klebsiella and of the structurally related colanic-acid polysaccharide of Escherichia coli in resistance to phagocytosis and serum killing.
    Allen PM; Fisher D; Saunders JR; Hart CA
    J Med Microbiol; 1987 Dec; 24(4):363-70. PubMed ID: 3320374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of K1-encapsulated Escherichia coli to killing by the bactericidal/permeability-increasing protein of rabbit and human neutrophils.
    Weiss J; Victor M; Cross AS; Elsbach P
    Infect Immun; 1982 Dec; 38(3):1149-53. PubMed ID: 6759406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electron microscopic study of phagocytosis of Escherichia coli by human polymorphonuclear leukocytes.
    Rozenberg-Arska M; Salters ME; van Strijp JA; Geuze JJ; Verhoef J
    Infect Immun; 1985 Dec; 50(3):852-9. PubMed ID: 3905616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential uptake and killing potential of Campylobacter jejuni by human peripheral monocytes/macrophages.
    Wassenaar TM; Engelskirchen M; Park S; Lastovica A
    Med Microbiol Immunol; 1997 Oct; 186(2-3):139-44. PubMed ID: 9403842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of superoxide dismutase in resistance of Porphyromonas gingivalis to killing by polymorphonuclear leukocytes.
    Amano A; Ishimoto T; Tamagawa H; Shizukuishi S
    Infect Immun; 1992 Feb; 60(2):712-4. PubMed ID: 1309723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes.
    Johnston RB; Keele BB; Misra HP; Lehmeyer JE; Webb LS; Baehner RL; RaJagopalan KV
    J Clin Invest; 1975 Jun; 55(6):1357-72. PubMed ID: 166094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefdinir-induced modification of the susceptibility of bacteria to the antibacterial activity of human serum and polymorphonuclear neutrophils.
    Pruul H; McDonald PJ
    Eur J Clin Microbiol Infect Dis; 1993 Mar; 12(3):170-6. PubMed ID: 8508815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of periplasmic Cu,Zn superoxide dismutase enhances survival of Escherichia coli invasive strains within nonphagocytic cells.
    Battistoni A; Pacello F; Folcarelli S; Ajello M; Donnarumma G; Greco R; Ammendolia MG; Touati D; Rotilio G; Valenti P
    Infect Immun; 2000 Jan; 68(1):30-7. PubMed ID: 10603365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-opsonisation of Escherichia coli induces resistance to neutrophil killing in serum and urine: relationship to growth phase.
    Gargan RA; Brumfitt W; Hamilton-Miller JM
    J Med Microbiol; 1991 Jul; 35(1):12-7. PubMed ID: 1677047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Killing of Escherichia coli strains from clinical specimens in human serum and polymorphonuclear leucocytes.
    Kumar S; Rizvi M
    Indian J Pathol Microbiol; 2002 Apr; 45(2):173-5. PubMed ID: 12696734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phagocytic resistance of Escherichia coli K-1 isolates and relationship to virulence.
    Weinstein R; Young LS
    J Clin Microbiol; 1978 Dec; 8(6):748-55. PubMed ID: 370149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.